V. Le Mabecque

697 citations

17 papers · 482 indexed · h-index 12

Impact in

Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing

Papers in

Molecular Medicine 5
- Antibiotic Resistance in Bacteria 5
Infectious Diseases 13
- Antimicrobial Resistance in Staphylococcus 12

Co-authors: Cédric Jacqueline J. Caillon G. Potel A.-F. Miegeville Denis Bugnon Éric Batard Gilles Amador Antoine Hamel
Journals: Journal of Antimicrobial Chemotherapy (6 papers)Antimicrobial Agents and Chemotherapy (6 papers)International Journal of Antimicrobial Agents (2 papers)Letters in Applied Microbiology (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)
Partner nations: France

In The Last Decade

V. Le Mabecque

17 papers receiving 457 citations

Peers

Countries citing papers authored by V. Le Mabecque

Since Specialization

Citations

This map shows the geographic impact of V. Le Mabecque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Le Mabecque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Le Mabecque more than expected).

Fields of papers citing papers by V. Le Mabecque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Le Mabecque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Le Mabecque. The network helps show where V. Le Mabecque may publish in the future.

Co-authors

The 25 scholars most cited alongside V. Le Mabecque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with V. Le Mabecque Line = papers co-authored together V. Le Mabecque links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Live intramacrophagic Staphylococcus aureus as a potential cause of antibiotic therapy failure: observations in an in vivo mouse model of prosthetic vascular material infections Journal of Antimicrobial Chemotherapy ·粱金茹, Karine Steenkeste, Cédric Jacqueline, Romain Briandet, J. Caillon, David Boutoille, V. Le Mabecque, Pierre Tattevin, Marie‐Pierre Fontaine‐Aupart, Matthieu Revest	2018	5
2	Newin vitroandin vivomodels to evaluate antibiotic efficacy inStaphylococcus aureusprosthetic vascular graft infection Journal of Antimicrobial Chemotherapy ·Matthieu Revest, Cédric Jacqueline, 粱金茹, J. Caillon, V. Le Mabecque, P. Luna, Karine Steenkeste, Pierre Tattevin, G. Potel, C. Michelet, Georgeta Carmen Holban, David Boutoille	2016	19
3	A delivery system of linezolid to enhance the MRSA osteomyelitis prognosis: in vivo experimental assessment European Journal of Clinical Microbiology & Infectious Diseases ·Alexis Gaudin, Cédric Jacqueline, H Gautier, Wang Fujiang, V. Le Mabecque, A.-F. Miegeville, G. Potel, Jean‐Michel Bouler, Pierre Weiss, J. Caillon, Gilles Amador	2012	6
4	Efficacy of ceftolozane in a murine model of Pseudomonas aeruginosa acute pneumonia: in vivo antimicrobial activity and impact on host inflammatory response Journal of Antimicrobial Chemotherapy ·Cédric Jacqueline, Antoine Roquilly, Wang Fujiang, David Boutoille, Alexis Broquet, V. Le Mabecque, Gilles Amador, G. Potel, J. Caillon, Karim Asehnoune	2012	26
5	Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus Journal of Antimicrobial Chemotherapy ·Cédric Jacqueline, Gilles Amador, Éric Batard, V. Le Mabecque, A.-F. Miegeville, D. Biek, J. Caillon, G. Potel	2011	31
6	Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis International Journal of Antimicrobial Agents ·Mathilde Lefebvre, Cédric Jacqueline, Gilles Amador, V. Le Mabecque, Craig Jancerak, G. Potel, J. Caillon, Nathalie Asseray	2010	53
7	A new experimental model of acute osteomyelitis due to methicillin-resistant Staphylococcus aureus in rabbit Letters in Applied Microbiology ·Alexis Gaudin, Gilles Amador, Antoine Hamel, V. Le Mabecque, A.-F. Miegeville, G. Potel, J. Caillon, Cédric Jacqueline	2010	19
8	Efficacy of the new cephalosporin ceftaroline in the treatment of experimental methicillin-resistant Staphylococcus aureus acute osteomyelitis Journal of Antimicrobial Chemotherapy ·Cédric Jacqueline, Gilles Amador, J. Caillon, V. Le Mabecque, Éric Batard, A.-F. Miegeville, D. Biek, Zhou Linhao, G. Potel, Antoine Hamel	2010	54
9	Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem Journal of Antimicrobial Chemotherapy ·Cédric Bretonnière, Cédric Jacqueline, J. Caillon, Christophe Guitton, V. Le Mabecque, Craig Jancerak, D. Villers, G. Potel, David Boutoille	2010	12
10	In Vivo Activity of a Novel Anti-Methicillin-Resistant Staphylococcus aureus Cephalosporin, Ceftaroline, against Vancomycin-Susceptible and -Resistant Enterococcus faecalis Strains in a Rabbit Endocarditis Model: a Comparative Study with Linezolid and Vancomycin Antimicrobial Agents and Chemotherapy ·Cédric Jacqueline, J. Caillon, V. Le Mabecque, A.-F. Miegeville, Yigong Ge, Donald Biek, Éric Batard, G. Potel	2009	24
11	In vivo impact of the MexAB-OprM efflux system on β-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection International Journal of Antimicrobial Agents ·David Boutoille, Cédric Jacqueline, V. Le Mabecque, G. Potel, J. Caillon	2009	7
12	In Vivo Assessment of the Antimicrobial Activity of a Calcium-Deficient Apatite Vancomycin Drug Delivery System in a Methicillin-Resistant Staphylococcus aureus Rabbit Osteomyelitis Experimental Model Antimicrobial Agents and Chemotherapy ·Gilles Amador, H Gautier, V. Le Mabecque, Craig Jancerak, G. Potel, Jean‐Michel Bouler, Pierre Weiss, J. Caillon, Cédric Jacqueline	2009	8
13	In Vivo Efficacy of Ceftaroline (PPI-0903), a New Broad-Spectrum Cephalosporin, Compared with Linezolid and Vancomycin against Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus in a Rabbit Endocarditis Model Antimicrobial Agents and Chemotherapy ·Cédric Jacqueline, J. Caillon, V. Le Mabecque, A.-F. Miegeville, Antoine Hamel, Denis Bugnon, B. A. Krynetsky, G. Potel	2007	94
14	In Vitro and In Vivo Assessment of Linezolid Combined with Ertapenem: a Highly Synergistic Combination against Methicillin-Resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy ·Cédric Jacqueline, J. Caillon, Olivier Grossi, V. Le Mabecque, A.-F. Miegeville, Denis Bugnon, Éric Batard, G. Potel	2006	28
15	Activity of Glycopeptides against Staphylococcus aureus Infection in a Rabbit Endocarditis Model: MICs Do Not Predict In Vivo Efficacy Antimicrobial Agents and Chemotherapy ·Nathalie Asseray, Cédric Jacqueline, V. Le Mabecque, Éric Batard, Denis Bugnon, G. Potel, J. Caillon	2005	17
16	In Vitro and In Vivo Synergistic Activities of Linezolid Combined with Subinhibitory Concentrations of Imipenem against Methicillin-Resistant Staphylococcus aureus Antimicrobial Agents and Chemotherapy ·Cédric Jacqueline, Dominique Navas, Éric Batard, A.-F. Miegeville, V. Le Mabecque, Marie-France Kerguéris, Denis Bugnon, G. Potel, J. Caillon	2004	77
17	Activité de l’amoxicilline in vivo dans l’endocardite expérimentale du lapin à Corynebacterium diphtheriae non toxinogène Pathologie Biologie ·Martin Willburger, Cédric Jacqueline, V. Le Mabecque, O. Patey, G. Potel, Denis Bugnon, J. Caillon	2002	2

About V. Le Mabecque

V. Le Mabecque is a scholar working on Molecular Medicine, Infectious Diseases, Pharmacology, Clinical Biochemistry and Epidemiology, having authored 17 papers that have together received 482 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Infective Endocarditis Diagnosis and Management (6 papers), Orthopedic Infections and Treatments (6 papers), Antibiotic Resistance in Bacteria (5 papers), Pneumonia and Respiratory Infections (3 papers), Bacterial biofilms and quorum sensing (3 papers) and Bacterial Identification and Susceptibility Testing (2 papers). The work is most often cited by research in Molecular Medicine (109 citations), Clinical Biochemistry (133 citations), Infectious Diseases (321 citations), Pharmacology (179 citations) and Applied Microbiology and Biotechnology (15 citations). V. Le Mabecque has collaborated with scholars based in France. Frequent co-authors include Cédric Jacqueline, J. Caillon, G. Potel, A.-F. Miegeville, Denis Bugnon, Éric Batard, Gilles Amador, Antoine Hamel, Dominique Navas and Nathalie Asseray. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, International Journal of Antimicrobial Agents, Letters in Applied Microbiology and European Journal of Clinical Microbiology & Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact